Psilocybin a Step Closer to Legalization

With support from the US FDA and several clinical studies, psilocybin is emerging as a way to help treat mental illness – great news for companies such as Pure Extracts Technologies Corp. (CSE:PULL)(OTC:PRXTF), Psyence Group Inc. (CSE:PSYG), Compass Pathways Inc. (NASDAQ:CMPS), Cybin Inc. (NEO:CYBN)(OTC:CLXPF), and MindMed (NEO:MMED)(OTC:MMEDF). For example, a study from JAMA Psychiatry just … Continue reading “Psilocybin a Step Closer to Legalization”